SuperGen presents informatin on a new PIM kinase inhibitor SGI-1776 at the 2008 AACR Annual Meeting that that it has identified a lead PIM kinase inhibitor, , that causes tumor regression in acute myologenous leukemia (AML) xenograft models (Abstract No. 4974).
Filed under: kinase | Tagged: kinase, PIM, SGI-1776, SGI1776, Supergen
Name
E-mail (will not be published)
Website
Notify me of follow-up comments via email.
